| Literature DB >> 34433009 |
Magdalena Socha1, Anna Sowińska-Seidler1, Uirá Souto Melo2, Bjørt K Kragesteen3, Martin Franke4, Verena Heinrich5, Robert Schöpflin6, Inga Nagel7, Nicolas Gruchy8, Stefan Mundlos9, Varun K A Sreenivasan10, Cristina López11, Martin Vingron5, Ewelina Bukowska-Olech1, Malte Spielmann12, Aleksander Jamsheer13.
Abstract
Copy-number variations (CNVs) are a common cause of congenital limb malformations and are interpreted primarily on the basis of their effect on gene dosage. However, recent studies show that CNVs also influence the 3D genome chromatin organization. The functional interpretation of whether a phenotype is the result of gene dosage or a regulatory position effect remains challenging. Here, we report on two unrelated families with individuals affected by bilateral hypoplasia of the femoral bones, both harboring de novo duplications on chromosome 10q24.32. The ∼0.5 Mb duplications include FGF8, a key regulator of limb development and several limb enhancer elements. To functionally characterize these variants, we analyzed the local chromatin architecture in the affected individuals' cells and re-engineered the duplications in mice by using CRISPR-Cas9 genome editing. We found that the duplications were associated with ectopic chromatin contacts and increased FGF8 expression. Transgenic mice carrying the heterozygous tandem duplication including Fgf8 exhibited proximal shortening of the limbs, resembling the human phenotype. To evaluate whether the phenotype was a result of gene dosage, we generated another transgenic mice line, carrying the duplication on one allele and a concurrent Fgf8 deletion on the other allele, as a control. Surprisingly, the same malformations were observed. Capture Hi-C experiments revealed ectopic interaction with the duplicated region and Fgf8, indicating a position effect. In summary, we show that duplications at the FGF8 locus are associated with femoral hypoplasia and that the phenotype is most likely the result of position effects altering FGF8 expression rather than gene dosage effects.Entities:
Keywords: FGF8; TADs; enhancer; femoral hypoplasia; non-coding mutations; position effects
Mesh:
Substances:
Year: 2021 PMID: 34433009 PMCID: PMC8456176 DOI: 10.1016/j.ajhg.2021.08.001
Source DB: PubMed Journal: Am J Hum Genet ISSN: 0002-9297 Impact factor: 11.025